76 related articles for article (PubMed ID: 21830545)
21. O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?
Widhalm G; Wolfsberger S; Preusser M; Woehrer A; Kotter MR; Czech T; Marosi C; Knosp E
Cancer; 2009 Mar; 115(5):1070-80. PubMed ID: 19156926
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors.
Hirohata T; Asano K; Ogawa Y; Takano S; Amano K; Isozaki O; Iwai Y; Sakata K; Fukuhara N; Nishioka H; Yamada S; Fujio S; Arita K; Takano K; Tominaga A; Hizuka N; Ikeda H; Osamura RY; Tahara S; Ishii Y; Kawamata T; Shimatsu A; Teramoto A; Matsuno A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1130-6. PubMed ID: 23365123
[TBL] [Abstract][Full Text] [Related]
23. Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.
Raverot G; Castinetti F; Jouanneau E; Morange I; Figarella-Branger D; Dufour H; Trouillas J; Brue T
Clin Endocrinol (Oxf); 2012 Jun; 76(6):769-75. PubMed ID: 22404748
[TBL] [Abstract][Full Text] [Related]
24. Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.
McCormack AI; Wass JA; Grossman AB
Eur J Clin Invest; 2011 Oct; 41(10):1133-48. PubMed ID: 21496012
[TBL] [Abstract][Full Text] [Related]
25. Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm.
Syro LV; Uribe H; Penagos LC; Ortiz LD; Fadul CE; Horvath E; Kovacs K
Clin Endocrinol (Oxf); 2006 Oct; 65(4):552-3. PubMed ID: 16984254
[No Abstract] [Full Text] [Related]
26. Prophylactic radiotherapy for glioblastoma in the elderly.
Tartarone A; Ardito R; Romano C
N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
[No Abstract] [Full Text] [Related]
27. Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer.
Robins HI; Traynor AM; Mehta M
J Thorac Oncol; 2006 Sep; 1(7):732-3; author reply 733. PubMed ID: 17409946
[No Abstract] [Full Text] [Related]
28. Treatment of brain metastases from melanoma.
Legha SS
J Clin Oncol; 2005 May; 23(13):3155; author reply 3155-6. PubMed ID: 15860880
[No Abstract] [Full Text] [Related]
29. Treatment of brain metastases of malignant melanoma with temozolomide.
Biasco G; Pantaleo MA; Casadei S
N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
[No Abstract] [Full Text] [Related]
30. Chemotherapy for glioblastoma multiforme (GBM).
Roitberg B
Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
[No Abstract] [Full Text] [Related]
31. Pituitary carcinoma presenting with multiple metastases: case report.
Guzel A; Tatli M; Senturk S; Guzel E; Cayli SR; Sav A
J Child Neurol; 2008 Dec; 23(12):1467-71. PubMed ID: 19073854
[TBL] [Abstract][Full Text] [Related]
32. New drug extends lives of brain cancer patients.
FDA Consum; 2005; 39(4):3. PubMed ID: 16252389
[No Abstract] [Full Text] [Related]
33. Defining the standard of care for high-grade glioma--a NICE deal for patients.
Taylor RE
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):97-8. PubMed ID: 17951034
[No Abstract] [Full Text] [Related]
34. NRAS-mutant melanoma: response to chemotherapy.
Soon CW; Algazi AP; Cha EN; Webb EM; Daud AI
Arch Dermatol; 2011 May; 147(5):626-7. PubMed ID: 21576590
[No Abstract] [Full Text] [Related]
35. Treatment of brain tumors.
Seiter K
N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012
[No Abstract] [Full Text] [Related]
36. [Temodal--an alkylating cytostatic agent. Effectiveness in patients with malignant gliomas].
Matsko MV
Vopr Onkol; 2012; 58(3):425-8. PubMed ID: 22888663
[No Abstract] [Full Text] [Related]
37. [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
Zheludkova OG; Tarasova IS; Gorbatykh SV; Belogurova MB; Kumirova EV; Borodina ID; Prityko AG; Melikian AG; Shcherbenko OI
Vopr Onkol; 2002; 48(3):356-60. PubMed ID: 12455362
[No Abstract] [Full Text] [Related]
38. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
Treudler R; Georgieva J; Geilen CC; Orfanos CE
J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.
Chan AT; Leung TW; Kwan WH; Mok TS; Yeo W; Lai M; Johnson PJ
Cancer Chemother Pharmacol; 1998; 42(3):247-9. PubMed ID: 9685061
[TBL] [Abstract][Full Text] [Related]
40. [Problems of chemotherapy for glioma].
Hirose Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
